Pieris Pharmaceuticals (PIRS)
NASDAQ:PIRS
Holding PIRS?
Track your performance easily

Pieris Pharmaceuticals (PIRS) Ownership - Who Owns Pieris Pharmaceuticals?

590 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 12, 2024
xxxxxxxxxxxxx
$92310

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
116,500Institution8.82%1,979,335
81,145Institution6.15%1,378,654
39,475Institution2.99%670,680
35,732Institution2.71%607,087
29,063Institution2.20%493,780
16,645Institution1.26%282,799
11,069Institution0.84%188,062
11,069Institution0.84%188,062

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
116,500Institution8.82%1,979,335
81,145Institution6.15%1,378,654
39,475Institution2.99%670,680
35,732Institution2.71%607,087
29,063Institution2.20%493,780
16,645Institution1.26%282,799
11,069Institution0.84%188,062

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
11,069Institution0.84%183,745

FAQ

Who Owns Pieris Pharmaceuticals (PIRS)?
Currently, no data Available
What percentage of Pieris Pharmaceuticals (PIRS) stock is held by institutional investors?
Currently, no data Available
What percentage of Pieris Pharmaceuticals (PIRS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Pieris Pharmaceuticals (PIRS)?
Bridgeway Funds, Inc. owns the most shares of Pieris Pharmaceuticals (PIRS).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis